We can come close to what revenues will be reported. On Nov 1 Eisai will report their numbers. To have a close call on these revenues, they seem to be about 50M+ a quarter on dacogen sales.
So astx will report the third quarter number and since they are hovering around $50M a quarter and the percentage goes up every $50 million, this would be the 25% quarter. Maybe old jelly can confirm. So ball park we see $54M times 25% or 13.50M+ in revenues. Expenses are a little bit harder to predict with the merger and consolidation.
I suugest you watch eisai reported numbers, on Nov 1, usually you can view them late on the 31, because they are reported from Japan. We want a number above $54M. There are a few here that will do there homework and provide a number as soon as it's released. I jus wonder who listens to the presentation. I never hear anything from longs, that they listen to it. That couldn't be since they all may be the same individual, but that should be resolved soon. But don't hold your breath.
How about exitman. He sure has been quite. Did he cut and run. He had some nice analyst comments, but has been quite since I ask him about his background.